Why it was recalled
Lack of assurance of sterility:
Product description
fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2001-2
Lot numbers, UPCs & expiration codes
Lot:17-275321, Exp. 10/3/2023; 17-275779, 17-275790, Exp. 10/10/2023.
Where it was sold
Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0024-2024
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Sep 21, 2023
- FDA report date
- Oct 11, 2023
- Quantity
- 962 30 mL syringes.
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Central Admixture Pharmacy Services Inc
Original FDA data
Every field from FDA enforcement report D-0024-2024, exactly as published.
Show all FDA fields
- City
- San Diego
- State
- CA
- Status
- Terminated
- Country
- United States
- Event ID
- 93103
- Address
- 7935 Dunbrook Rd Ste C
- Code information
- Lot:17-275321, Exp. 10/3/2023; 17-275779, 17-275790, Exp. 10/10/2023.
- Postal code
- 92126-6322
- Report date
- Oct 11, 2023
- Product type
- Drugs
- Recall number
- D-0024-2024
- Classification
- Class II
- Recalling firm
- Central Admixture Pharmacy Services Inc
- Product quantity
- 962 30 mL syringes.
- Termination date
- Mar 19, 2025
- Reason for recall
- Lack of assurance of sterility:
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2001-2
- Distribution pattern
- Nationwide in the USA
- Recall initiation date
- Sep 21, 2023
- Initial firm notification
- Letter
- Center classification date
- Oct 4, 2023